SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-012945
Filing Date
2017-06-23
Accepted
2017-06-23 17:15:22
Documents
6
Period of Report
2017-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20170622.htm 8-K 35897
2 UNDERWRITING AGREEMENT sbph-ex11_7.htm EX-1.1 278570
3 MINTZ LEVIN LEGAL OPINION sbph-ex51_8.htm EX-5.1 14140
4 PRESS RELEASE sbph-ex991_6.htm EX-99.1 12570
5 GRAPHIC g201706231350033805633.jpg GRAPHIC 134172
6 GRAPHIC g201706231349509794166.jpg GRAPHIC 5029
  Complete submission text file 0001564590-17-012945.txt   534084
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 17928384
SIC: 2834 Pharmaceutical Preparations